Schedule 13D ownership disclosure

DSS INC

Common Stock, par value $0.02 per share · CUSIP: 26253C201

Event date: 2025-08-20

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Heng Fai Ambrose ChanReported CIK 0001261725

    Shares: 6,730,059.00 · Class: 69.6%

  • Alset Inc.Reported CIK 0001750106

    Shares: 4,542,606.00 · Class: 47.0%

  • Global Biomedical Pte. Ltd.

    Shares: 311,634.00 · Class: 3.4%

  • Alset International LimitedReported CIK 0001660984

    Shares: 1,379,943.00 · Class: 15.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001641172-25-025258
Form type
SCHEDULE 13D/A
Filer
Chan Heng Fai Ambrose
CIK
CIK 1261725
Filed
Aug 22, 2025
Reporting period
Aug 20, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub